HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Clinical trial NCT03603405 · RECRUITING
Trial details
- NCT number
- NCT03603405
- Sponsor
- The Methodist Hospital Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2026-12-31
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.